CEO Executive AssistantClinical and translational research is a strategic asset for healthcare organizations seeking to differentiate their clinical programs, attract top physician talent, and advance medical knowledge. For health systems with academic medical center affiliations or significant research infrastructure, research programs represent major investments in facilities, staff, equipment, and institutional support.
Research program management is inherently specialized. The regulatory requirements governing human subjects research, the federal grant management obligations, and the scientific governance frameworks required to maintain research integrity all require deep expertise that no CEO can personally possess. Yet research direction, funding strategy, and research program investments are strategic decisions that require CEO leadership.
The Research Leadership Structure
Healthcare organizations with significant research programs typically have a Chief Research Officer, VP of Research, or Research Institute Director who leads the research enterprise. In academic medical center environments, this may be the Chief Academic Officer or a designated research dean working in partnership with hospital leadership.
The research leader must combine scientific credibility with administrative and financial management capability. They need to be respected by physician-scientists and able to manage complex grant portfolios, regulatory compliance programs, and research infrastructure.
The CEO should ensure the research leader has appropriate authority and resources to lead the research enterprise effectively. A research leader who constantly has to fight for support from administration will spend energy on internal politics rather than science.
Core Research Functions to Delegate
Research program operations. Day-to-day management of active research studies, laboratory operations, clinical research coordinator staffing, and research participant management belongs to your research team.
IRB and human subjects compliance. Your Institutional Review Board and human subjects protection program should operate with full regulatory independence. The CEO ensures the IRB has adequate resources and organizational support but must not exert pressure on IRB decisions.
Federal grant management. Sponsored research administration, grant compliance, and federal reporting belong to your research administration team working in partnership with Principal Investigators.
Research faculty development. Mentorship programs for early-career investigators, research training programs, and researcher recruitment belong to research and academic leadership.
Industry partnerships and sponsored research. Managing relationships with pharmaceutical and device industry research sponsors belongs to your research team with legal and compliance oversight.
Research infrastructure management. Core facilities, laboratory space, equipment, and research IT belong to your research operations team.
What the CEO Must Personally Engage In
Research strategic direction. What research areas align with the organization’s clinical mission? How significant an investment should the organization make in research? How does research contribute to the organization’s competitive positioning? These strategic questions require CEO engagement.
Research funding and capital investment. Major investments in research infrastructure, research faculty recruitment packages, and research program launch costs require CEO and board approval.
Academic partnerships. For health systems with academic affiliations, the partnership agreements, resource sharing arrangements, and governance structures with affiliated universities require CEO-level relationship management.
Research regulatory compliance oversight. The CEO must ensure the organization’s human subjects protection program is resourced adequately and that research regulatory compliance is taken seriously. If the FDA or OHRP investigates research compliance issues, the CEO must be engaged in the response.
Research reputation and community standing. The organization’s reputation as a research institution affects physician recruitment, patient referrals from academic medical centers, and grant competitiveness. The CEO contributes to research reputation through public advocacy, community communications, and strategic investment decisions.
For guidance on how research delegation connects to broader clinical governance, see the healthcare CEO delegation framework.
Research Governance Structures
Effective research delegation requires formal governance structures that protect research integrity and ensure accountability.
Research oversight committee. An executive-level committee that reviews research program performance, approves major research investments, and monitors compliance. The CEO may chair this committee or designate the CMO or research leader.
Institutional Review Board. The IRB provides ethical and regulatory oversight of human subjects research. It must operate with genuine independence from organizational and financial pressures. IRB members should be protected from retaliation for decisions that conflict with organizational preferences.
Research conflict of interest program. A formal program to identify and manage financial conflicts of interest among investigators belongs to your research administration and compliance teams.
Data safety monitoring boards. For clinical trials, independent data safety monitoring boards provide ongoing safety oversight. Research leadership manages these structures.
Industry Research Partnerships
Many healthcare organizations partner with pharmaceutical and device companies to conduct clinical trials and translational research. These partnerships generate revenue, attract talent, and advance science, but they also create conflict of interest risks and compliance obligations.
The CEO should understand the organization’s research partnership strategy without managing individual study relationships. Key strategic questions include: What types of industry partnerships are appropriate given the organization’s mission? How do we maintain scientific independence and integrity in industry-sponsored research? Are our conflict of interest policies robust?
Your research leader and GC should co-own the governance of industry research partnerships, with escalation to the CEO when partnership terms raise significant mission or compliance concerns.
Research and Patient Care Integration
One of the most powerful aspects of a strong research program is how it elevates clinical care quality. Participation in clinical trials gives patients access to cutting-edge treatments. Research programs attract physician-scientists who bring advanced knowledge to clinical practice. Research cultures tend to produce environments of scientific rigor and continuous improvement.
The CEO should articulate this connection publicly and internally. Research is not a separate activity from patient care. For organizations with strong research programs, it is integral to delivering the best possible care.
Operationally, integrating research and clinical care requires coordination between research operations and clinical operations. Patient flow, clinical space, staff time, and EHR integration all require collaboration between your research and clinical leaders. The CEO ensures this collaboration is valued and resourced.
The healthcare delegation guide discusses how to structure operational integration across clinical and administrative domains.
Community Research Partnerships
For healthcare organizations with community health missions, community-based participatory research offers an important avenue for generating evidence on community health interventions. These partnerships involve community organizations as genuine research partners rather than simply subjects.
Community research partnerships require relationship-building and cultural competency that your research and community relations teams should lead. The CEO engages by championing the value of community-engaged research and ensuring it receives appropriate organizational support.
Research Program Financial Management
Research programs have complex financial structures: grant-funded activities with strict budget compliance requirements, industry-sponsored studies with negotiated payment terms, and institutionally-funded research that requires strategic justification.
Your research administration and finance teams should manage research financial operations. Key oversight concerns for the CEO include: Is the research enterprise financially sustainable? Are indirect cost recovery rates adequate? Are major grants at risk due to compliance issues?
The CFO and research leader should jointly report on research financial performance to the CEO. This provides the financial visibility the CEO needs without requiring personal management of grant budgets.
Conclusion
Research program delegation in healthcare requires a CEO who appreciates the strategic value of research, appoints strong research leadership with genuine authority and resources, maintains appropriate governance structures, and engages personally in the strategic and relationship dimensions of research leadership.
The CEO who gets research delegation right builds an organization that advances medical knowledge, attracts exceptional talent, delivers cutting-edge care, and earns the reputation of a true center of excellence.
Related Reading
For further context, explore Healthcare CEO Delegation for Accreditation and Compliance and Healthcare CEO Delegation for Business Development.